Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Titrated divisible transdermal buprenorphine versus standard buprenorphine patch in chronic non-malignant pain
2005-005365-11Phase 3Completed
- Sponsor
- Grünenthal GmbH
- Start
- Dec 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of buprenorphine in chronic pain (2 arms), sponsored by Grünenthal GmbH. Primary endpoints: Baseline-adjusted mean pain intensity at Visit 5 (Day 27-29) and Incidence of adverse events. Started Dec 2005; status: completed.
02
Drugs
buprenorphine
03
Conditions
chronic pain
Beyond the preview
Go deeper on 2005-005365-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005365-11.